Goldenrod (Herb/Suppl)

Brand and Other Names:solidago
  • Print

Suggested Dosing

Drink at least 2 L of water qDay while taking goldenrod

Tea

One cup of tea BID-QID between meals

Seep 1-2 tsp (3-5 g) of the dried herb in 150 mL boiling water for 5-10 minutes, strain.

Usual dose ranges from 6-12 g/day

Liquid Extract (1:1 in 25% ethanol)

0.5-2 mL BID-TID

Tincute (1:5 in 45% ethanol)

0.5-1 mL BID-TID

Next:

Suggested Uses

Diuretic, anti-inflammatory, antispasmodic, gout, rheumatism, arthritis, eczema, acute pulmonary tuberculosis, diabetes, liver enlargement, hemorrhoids, internal bleeding, allergic rhinitis, asthma, prostatic hypertrophy,"irrigation therapy" to increase urine flow to treat/prevent inflammatory disease of the lower urinary tract, urinary calculi, and kidney gravel

Efficacy

Insufficient information available about effectiveness. More studies needed

Previous
Next:

Interactions

Interaction Checker

and Goldenrod

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 

            Contraindicated (0)

              Serious - Use Alternative (0)

                Monitor Closely (0)

                  Minor (16)

                  • amiloride

                    goldenrod increases effects of amiloride by pharmacodynamic synergism. Minor/Significance Unknown.

                  • bendroflumethiazide

                    goldenrod increases effects of bendroflumethiazide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • bumetanide

                    goldenrod increases effects of bumetanide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • chlorothiazide

                    goldenrod increases effects of chlorothiazide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • chlorthalidone

                    goldenrod increases effects of chlorthalidone by pharmacodynamic synergism. Minor/Significance Unknown.

                  • cyclopenthiazide

                    goldenrod increases effects of cyclopenthiazide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • drospirenone

                    goldenrod increases effects of drospirenone by pharmacodynamic synergism. Minor/Significance Unknown.

                  • ethacrynic acid

                    goldenrod increases effects of ethacrynic acid by pharmacodynamic synergism. Minor/Significance Unknown.

                  • furosemide

                    goldenrod increases effects of furosemide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • hydrochlorothiazide

                    goldenrod increases effects of hydrochlorothiazide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • indapamide

                    goldenrod increases effects of indapamide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • methyclothiazide

                    goldenrod increases effects of methyclothiazide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • metolazone

                    goldenrod increases effects of metolazone by pharmacodynamic synergism. Minor/Significance Unknown.

                  • spironolactone

                    goldenrod increases effects of spironolactone by pharmacodynamic synergism. Minor/Significance Unknown.

                  • torsemide

                    goldenrod increases effects of torsemide by pharmacodynamic synergism. Minor/Significance Unknown.

                  • triamterene

                    goldenrod increases effects of triamterene by pharmacodynamic synergism. Minor/Significance Unknown.

                  Previous
                  Next:

                  Adverse Effects

                  Allergic symptoms

                  Previous
                  Next:

                  Warnings

                  Contraindications

                  Pollen hypersensitivity

                  Previous
                  Next:

                  Pregnancy & Lactation

                  Pregnancy Category: N/A

                  Lactation: N/A

                  Pregnancy Categories

                  A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

                  B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

                  C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

                  D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

                  X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

                  NA: Information not available.

                  Previous
                  Next:

                  Pharmacology

                  Metabolism: N/A

                  Excretion: N/A

                  Mechanism of Action

                  Saponins, flavonoids have diuretic effect w/o Na+ loss

                  Previous
                  Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.